Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.
about
Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemicNatural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic InfectionAntiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countriesA Novel Diagnostic Target in the Hepatitis C Virus GenomeAnalytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA QuantificationA paradigm shift to prevent HIV drug resistanceScaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysisCost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoringLong-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimensMonitoring HIV viral load in resource limited settings: still a matter of debate?Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, ChinaShould expectations about the rate of new antiretroviral drug development impact the timing of HIV treatment initiation and expectations about treatment benefits?Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settingsCost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and ZimbabweUniversal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo.Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assayRoutine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialIncidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort.Measures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals.Modeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited.Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapyCost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature.The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.Short communication: prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients.Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection.The use of pooled viral load testing to identify antiretroviral treatment failureSwitching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study.HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling studyPooled nucleic acid testing to detect antiretroviral treatment failure in Mexico.Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling studySimplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in CambodiaVirological failure and drug resistance during first line anti-retroviral treatment in Indonesia.Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?The cost-effectiveness of monitoring strategies for antiretroviral therapy of HIV infected patients in resource-limited settings: software toolLaboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness
P2860
Q21133704-F65C3C62-1CCF-4178-9F9E-0D637025E08AQ26775036-F8423ACD-EA0F-486D-A34E-3BE6CD3DD9FAQ27001286-423DD5FF-0D96-4643-B503-47DD8F59EC66Q27487878-63112569-F82E-4259-A812-8CBCBED239C6Q28354038-4C2A9F08-453F-49B2-8A89-91382AA0853BQ28472815-6C01C543-33F3-4164-A453-4C6AB1825001Q28476684-6EC4B0BF-B3F1-4A90-A01E-424FF9CDFEC6Q28482138-97A9A932-39D0-49ED-A020-01E83FD5C56CQ28485321-D1969BF0-5B76-4E21-A31A-50EDB89FC8A2Q28485511-40C36516-74C9-4008-B7F5-B11AF6928987Q28537961-5EA56C51-2EF5-47B5-96C1-6532F2A5321BQ28539995-0D02F024-1904-439E-9494-C633D8D6BB13Q28543578-1A939881-965C-4A82-97B3-C246311D666CQ28730357-1186CCDE-A2F2-46C7-99FA-9FDEAEEE02E8Q33397869-C667A622-A25A-4C71-968C-BD00D2CA8A0BQ33470290-500922DF-B4EE-4A02-9E97-B43918CBC44CQ33497943-0F2C7C8C-6462-409F-8CFD-703FC3A169E9Q33587553-B2673F7E-14C5-40B0-B501-71F34902D918Q33611305-B663D4FC-C069-4968-9989-5F6711517655Q33813587-4DFC66DE-2EC5-4B41-A31C-02A8E1834ED5Q33854542-67B0C042-B0F1-4CE2-AB5B-1FA3E9DEBCD0Q33873614-F8E99788-3BAA-4E8E-AD22-069B59BDF122Q33893797-1C5BBA60-2869-4662-9A51-0651D203D283Q33959260-2D4DBAAE-CF9A-491C-9E3C-A78B244A305BQ33988234-69279EC5-B6F8-4548-943E-0F05A7C9838FQ34040080-B731F55F-1AFC-4C02-B932-9CE547C5239DQ34042986-8231D6E8-23FD-4D0C-B6A3-1C4B5CEB23C2Q34043003-6AAA5249-9538-4321-9BB1-FB8ADABED902Q34208678-C3F4CB23-F700-44A1-9FA2-D053977A4333Q34289544-DFB664C5-74BB-44FB-A83A-F41CE1676D2BQ34339523-BEB756D7-5CDD-4E35-9E2E-354F54020BAFQ34508454-3AF41208-6A62-41DD-9A35-15ACF3C3C257Q34574727-C045FD23-882C-4B5F-924D-954CB431C11FQ34612284-59F97055-EB7E-4557-BB6A-02113151D52CQ34730386-5E4B34E3-3B52-4C2F-96F7-A265AAB5D61DQ34748343-9FCB38E8-B21C-4A22-9F9B-819081833476Q35049762-D4DD13FF-BAA8-483F-90F4-5D4F64159713Q35185677-78E86069-7E96-44A9-BD8D-479CF0A9F57EQ35202699-7277D2C3-B9C0-4FEF-8CEC-779B9F32BF62Q35217495-7256ED0B-9B79-4C1E-98B5-E7C469AEC726
P2860
Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Outcomes from monitoring of pa ...... : a computer simulation model.
@en
Outcomes from monitoring of pa ...... : a computer simulation model.
@nl
type
label
Outcomes from monitoring of pa ...... : a computer simulation model.
@en
Outcomes from monitoring of pa ...... : a computer simulation model.
@nl
prefLabel
Outcomes from monitoring of pa ...... : a computer simulation model.
@en
Outcomes from monitoring of pa ...... : a computer simulation model.
@nl
P2093
P50
P1433
P1476
Outcomes from monitoring of pa ...... : a computer simulation model.
@en
P2093
Alec H Miners
Andrew N Phillips
Diane E Bennett
P304
P356
10.1016/S0140-6736(08)60624-8
P407
P577
2008-04-01T00:00:00Z